Dr. Ameyo Dorkenoo Ameyo


Country: Togo

Lymphatic Filariasis Program Coordinator, Ministry of Health

Dr. Dorkenoo has been the Lymphatic Filariasis (LF) Program Coordinator for six years. Togo is the first country in Africa to interrupt transmission of LF, due in no small part to her passion and commitment. She oversaw the mass administration of ivermectin and albendazole in the country’s seven LF-endemic districts, and then confirmed that transmission was interrupted via transmission assessment surveys conducted in 2009 and 2012. Dr. Dorkenoo continues to participate in the fight against LF by designing effective, highly innovative approaches to LF surveillance throughout Togo, as well as advocating for LF morbidity management and conducting nationwide lymphedema management training programs for healthcare workers. She has led nationwide integrated mapping of three NTDs, an integrated NTD coverage survey and other activities in the field. While preferring to stay out of the limelight, she is a valuable resource for the Integrated NTD Program, providing technical assistance and public health and laboratory experience. Her scientific integrity and expanding list of publications have helped draw attention to Togo’s successes in NTD control.


    Twitter: ENDinAfrica